Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,300.00
-120.00 (-2.21%)
At close: Jun 1, 2026
Market Cap61.66B -16.4%
Revenue (ttm)82.18B -4.4%
Net Income6.95B -45.1%
EPSn/a
Shares Out 11.38M
PE Ratio8.87
Forward PEn/a
Dividend190.00 (3.51%)
Ex-Dividend DateDec 29, 2025
Volume66,942
Open5,400.00
Previous Close5,420.00
Day's Range5,200.00 - 5,420.00
52-Week Range5,300.00 - 6,930.00
Beta0.58
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About Sinil Pharmaceutical

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In ... [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 287
Stock Exchange KOSDAQ
Ticker Symbol 012790
Full Company Profile

Financial Performance

In 2025, Sinil Pharmaceutical's revenue was 80.56 billion, a decrease of -9.92% compared to the previous year's 89.44 billion. Earnings were 7.53 billion, a decrease of -47.34%.

Financial Statements